Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

Cited In for PubMed (Select 8678194)

1.

Advances in the Management of Treatment-Resistant Depression.

Holtzheimer PE.

Focus (Am Psychiatr Publ). 2010 Fall;8(4):488-500.

2.

Sprouty2 in the dorsal hippocampus regulates neurogenesis and stress responsiveness in rats.

Dow AL, Lin TV, Chartoff EH, Potter D, McPhie DL, Van't Veer AV, Knoll AT, Lee KN, Neve RL, Patel TB, Ongur D, Cohen BM, Carlezon WA Jr.

PLoS One. 2015 Mar 30;10(3):e0120693. doi: 10.1371/journal.pone.0120693. eCollection 2015.

3.

Modulation of interhemispheric functional coordination in electroconvulsive therapy for depression.

Wei Q, Tian Y, Yu Y, Zhang F, Hu X, Dong Y, Chen Y, Hu P, Hu X, Wang K.

Transl Psychiatry. 2014 Sep 30;4:e453. doi: 10.1038/tp.2014.101.

4.

Leukocyte Gene Expression in Patients with Medication Refractory Depression before and after Treatment with ECT or Isoflurane Anesthesia: A Pilot Study.

Iacob E, Tadler SC, Light KC, Weeks HR, Smith KW, White AT, Hughen RW, VanHaitsma TA, Bushnell LA, Light AR.

Depress Res Treat. 2014;2014:582380. doi: 10.1155/2014/582380. Epub 2014 Apr 13.

5.

Current electroconvulsive therapy practice and research in the geriatric population.

Kerner N, Prudic J.

Neuropsychiatry (London). 2014 Feb;4(1):33-54.

6.

Antidepressant and neurocognitive effects of isoflurane anesthesia versus electroconvulsive therapy in refractory depression.

Weeks HR 3rd, Tadler SC, Smith KW, Iacob E, Saccoman M, White AT, Landvatter JD, Chelune GJ, Suchy Y, Clark E, Cahalan MK, Bushnell L, Sakata D, Light AR, Light KC.

PLoS One. 2013 Jul 26;8(7):e69809. doi: 10.1371/journal.pone.0069809. Print 2013.

7.

Relapse following successful electroconvulsive therapy for major depression: a meta-analysis.

Jelovac A, Kolshus E, McLoughlin DM.

Neuropsychopharmacology. 2013 Nov;38(12):2467-74. doi: 10.1038/npp.2013.149. Epub 2013 Jun 18.

8.

Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review.

Tokutsu Y, Umene-Nakano W, Shinkai T, Yoshimura R, Okamoto T, Katsuki A, Hori H, Ikenouchi-Sugita A, Hayashi K, Atake K, Nakamura J.

Clin Psychopharmacol Neurosci. 2013 Apr;11(1):34-8. doi: 10.9758/cpn.2013.11.1.34. Epub 2013 Apr 24.

9.

Association of cerebral metabolic activity changes with vagus nerve stimulation antidepressant response in treatment-resistant depression.

Conway CR, Chibnall JT, Gebara MA, Price JL, Snyder AZ, Mintun MA, Craig AD, Cornell ME, Perantie DC, Giuffra LA, Bucholz RD, Sheline YI.

Brain Stimul. 2013 Sep;6(5):788-97. doi: 10.1016/j.brs.2012.11.006. Epub 2013 Feb 13.

10.

Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.

Prudic J, Haskett RF, McCall WV, Isenberg K, Cooper T, Rosenquist PB, Mulsant BH, Sackeim HA.

J ECT. 2013 Mar;29(1):3-12. doi: 10.1097/YCT.0b013e31826ea8c4.

11.

Predictors of the short-term responder rate of Electroconvulsive therapy in depressive disorders--a population based study.

Nordenskjöld A, von Knorring L, Engström I.

BMC Psychiatry. 2012 Aug 17;12:115. doi: 10.1186/1471-244X-12-115.

12.

Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET.

Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R.

Mol Psychiatry. 2013 Jan;18(1):93-100. doi: 10.1038/mp.2012.93. Epub 2012 Jul 3.

13.

Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.

Mantovani A, Pavlicova M, Avery D, Nahas Z, McDonald WM, Wajdik CD, Holtzheimer PE 3rd, George MS, Sackeim HA, Lisanby SH.

Depress Anxiety. 2012 Oct;29(10):883-90. doi: 10.1002/da.21967. Epub 2012 Jun 11.

14.

Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response?

Conway CR, Chibnall JT, Gangwani S, Mintun MA, Price JL, Hershey T, Giuffra LA, Bucholz RD, Christensen JJ, Sheline YI.

J Affect Disord. 2012 Aug;139(3):283-90. doi: 10.1016/j.jad.2012.02.007. Epub 2012 Mar 5.

15.

Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder.

Conway CR, Sheline YI, Chibnall JT, Bucholz RD, Price JL, Gangwani S, Mintun MA.

Brain Stimul. 2012 Apr;5(2):163-71. doi: 10.1016/j.brs.2011.03.001. Epub 2011 Apr 3.

16.

Depression in late life.

Barry DL.

Dialogues Clin Neurosci. 1999 Sep;1(2):57-65.

17.

Symptom predictors of response to electroconvulsive therapy in older patients with treatment-resistant depression.

Tominaga K, Okazaki M, Higuchi H, Utagawa I, Nakamura E, Yamaguchi N.

Int J Gen Med. 2011;4:515-9. doi: 10.2147/IJGM.S21029. Epub 2011 Jul 8.

18.

Electroacupuncture for residual insomnia associated with major depressive disorder: a randomized controlled trial.

Yeung WF, Chung KF, Tso KC, Zhang SP, Zhang ZJ, Ho LM.

Sleep. 2011 Jun 1;34(6):807-15. doi: 10.5665/SLEEP.1056.

19.

Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial.

Blumberger DM, Mulsant BH, Emeremni C, Houck P, Andreescu C, Mazumdar S, Whyte E, Rothschild AJ, Flint AJ, Meyers BS.

J Psychiatr Res. 2011 Jul;45(7):896-901. doi: 10.1016/j.jpsychires.2011.01.003. Epub 2011 Feb 5.

20.

Deep brain stimulation for treatment-resistant depression.

Holtzheimer PE 3rd, Mayberg HS.

Am J Psychiatry. 2010 Dec;167(12):1437-44. doi: 10.1176/appi.ajp.2010.10010141. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk